Brief: Peptidream Inc - To Sell About Half Of Its Stake In Rayzebio Inc For $20.9 Million Due To U.S. Company's Nasdaq Listing
15/09/2023 04:35
Sept 15 (Reuters) - PeptiDream Inc 4587.T :
* TO SELL ABOUT HALF OF ITS STAKE IN RAYZEBIO INC FOR $20.9
MILLION DUE TO U.S. COMPANY'S NASDAQ LISTING
Source text for Eikon: ID:nTSuo874da
Further company coverage: 4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner